Shop
Checkout
CONFERENCES
REPORTS
MEDIA
PROFESSIONAL
EDUCATIONAL

Industry Dynamics & Strategic Issues

The New Generation of Antibody Therapeutics
June 2012
Table of Contents | Tables and Figures


Back-Up Compound Strategies
April 2012
Table of Contents | Tables and Figures | Executive Summary


Hematological Cancer Therapies: Pipelines, Markets, and Business Considerations
February 2012
Table of Contents | Tables and Figures


High-Content Analysis Report
December 2011
Table of Contents | Tables and Figures


New Trends in Preventive and Therapeutic Vaccines
October 2011
Table of Contents | Tables and Figures | Executive Summary


Cytokine-Based Therapies and Inhibitors:R&D Pipelines, Markets, and Strategic Issues
September 2011
Table of Contents | Tables and Figures | Executive Summary


Kinase-Targeted Therapeutics
August 2011
Table of Contents | Tables and Figures | Executive Summary
Engineering Next-Generation Therapeutic Proteins
July 2011
Table of Contents | Tables and Figures


Commercializing Biomarkers in Therapeutic and Diagnostic Applications
May 2011
Table of Contents | Tables and Figures | Executive Summary


Advanced Drug Delivery Technologies
January 2011
Table of Contents | Tables and Figures | Executive Summary


Next-Generation Sequencing Technologies: Applications and Markets
October 2010
Table of Contents | Tables and Figures | Executive Summary


Drug Repositioning
July 2010
Table of Contents | Tables and Figures | Executive Summary


Combination Drug/Diagnostics: Fueling Growth of Personalized Medicine
April 2010
Table of Contents | Tables and Figures | Executive Summary


Kinase Therapeutics: Pipeline Assessment and Commercial Prospects
January 2010
Table of Contents | Tables and Figures | Executive Summary


Strategic Alliances: Synergistic Path to Value Creation
January 2010
Table of Contents | Tables and Figures | Executive Summary


Outsourcing Preclinical Studies to China
July 2009
Table of Contents | Tables and Figures | Executive Summary
Pharmacogenomics: Delivering on the Promise
June 2009
Table of Contents | Tables and Figures | Executive Summary
Bioinformatics and Computational Biology: Bottlenecks and Options
June 2009
Table of Contents | Tables and Figures | Executive Summary
Approaches to Reducing Phase II Attrition
May 2009
Table of Contents | Tables and Figures | Executive Summary
Direct-To-Consumer Genetic Testing: Business Prospects in the United States
March 2009
Table of Contents | Tables and Figures | Executive Summary
Medicinal Chemistry for Drug Discovery: Significance of Recent Trends
March 2009
Table of Contents | Tables and Figures | Executive Summary
Neurodegenerative Diseases: Next-Generation Drugs for Four Major Disorders
December 2008
Table of Contents | Tables and Figures | Executive Summary

Conducting Clinical Trials in Europe: An Insider's Analysis
December 2008
Table of Contents | Tables and Figures | Executive Summary

Strategic Management of Resources and Portfolios
August 2008
Table of Contents | Tables and Figures | Executive Summary

Systems Biology: A Disruptive Technology
May 2008
Table of Contents | Tables and Figures | Executive Summary

Blood-Brain Barrier: Bridging Options for Drug Discovery & Development
May 2008
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Cardiotoxicity: Issues, Technologies, and Solutions for the Future
May 2008
Table of Contents | Tables and Figures | Executive Summary

Adaptive Clinical Trials: Innovation in Trial Design, Management, and Analysis
September 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Backup Compound Strategies: Best Practices for Reducing Phase II Risk
September 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Next-Generation Sequencing: Scientific and Commercial Implications of the $1000 Genome
August 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary
Biomarker SOPs: Getting Optimum Value from Your Biomarker Program
January 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary
Outlook for Predictive Safety Technologies
November 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Specialty Pharmaceuticals: Driving Industry Growth into the Next Decade
October 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Pharmaceutical R&D Productivity: The Path to Innovation
October 2005
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Powering Discovery through Target Evaluation: Moving Beyond the Validation Paradigm
August 2005
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Nutrigenomics: Impacts on Markets
June 2005
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

2015: Strategic Considerations for the US Pharmaceutical Industry
February 2005
Table of Contents | Tables and Figures | Survey Questions | Executive Summary